Answers are grounded in this paper and cite their sources.
Quasi-experimental study reveals low-dose aspirin effectively reduces preterm birth rates in pregnant women, suggesting improved neonatal health outcomes.
Objective: To evaluate the role of low-dose aspirin in preventing preterm births in pregnant women with a history of preterm labor. Study Design: Quasi-experimental study. Place and Duration of Study: Department of Obstetrics and Gynaecology, MTI-HMC Peshawar, from 18th Sep 2024 to 18th Mar 2025. Methodology: A total of 384 pregnant women with a history of preterm labor and gestational age between 6 and 20 weeks were included. Participants were allocated into two groups through a non-random sequential allocation method designed to ensure comparable group sizes. Women in Group A received 75 mg of low-dose aspirin daily until 37 weeks of gestation, while those in Group B received placebo. All analyses were performed using SPSS version 26.0. The chi-square test, with a p-value <0.05, is considered statistically significant. Results: The mean age was 30.01 ± 6.34 years in Group A and 28.98 ± 6.64 years in Group B, with similar parity. The mean gestational age at delivery was 33.41 ± 4.93 weeks in Group A and 27.40 ± 4.32 weeks in Group B. Preterm birth occurred in 20.3% of Group A compared to 81.3% of Group B (p < 0.001). The mean APGAR score at 1 minute was 8.04 ± 0.81 in Group A and 2.46 ± 1.76 in Group B, while at 5 minutes it was 8.41 ± 0.49 and 3.08 ± 1.96, respectively (p < 0.001). Conclusion: Low-dose aspirin significantly reduces preterm birth rates and improves neonatal outcomes, including APGAR scores and NICU admissions.
No takes yet. Share an insight, caveat, or question.
Maqsood et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: